BioAge (BIOA) stock cratered 70% Friday evening after the company said it was discontinuing a Phase 2 study for its ...
Despite recent tailwinds and growth, my view is high inflation has overstated Tri Pointe Homes' revenues and earnings. Read ...
Quantum computing and algorithmic trading models can enhance portfolio performance across various sectors. Read why strong ...
Nuvalent, Inc. has promising drugs, zidesamtinib and NVL-655, targeting NSCLC with encouraging data. Read why NUVL stock is a ...
Capricor Therapeutics is advancing deramiocel for DMD-related cardiomyopathy, with FDA approval potential by 2025. Read why ...
Toronto-Dominion Bank released its earnings Thursday. The release was mixed, beating on revenue but missing on adjusted ...
Richmond Mutual Bancorporation's dividend yield has decreased to 3.8% due to a 30% share price increase, making it less ...
Ameren's operating income and net income declined due to higher operating expenses and regulatory changes in Illinois. Read ...
Despite PepsiCo's solid financials and modest leverage, weak volume trends and political changes raise concerns. Read why PEP ...
Enterprise Products Partners is still discounted, judging by its PEGY ratio and comparison against close peers. Read why I've ...
The company is well diversified beyond automotive and QSRs, now spanning financial services, healthcare, and insurance ...
Yalla Group is sitting on a huge pile of cash and generating healthy cash flow each year, thus deserving a re-rating. Check ...